Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation

11 May 2018

Abstract excerpt

Transplantation-associated thrombotic microangiopathy (TA-TMA) is a serious complication of hematopoietic stem cell transplantation (HSCT). We characterized the incidence, risk factors, and long-term outcomes associated with TA-TMA by performing a comprehensive review of all adult patients (n = 1990) undergoing allogeneic HSCT at the Dana Farber Cancer Institute/Brigham and Women's Hospital between 2005 and 2013....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Complement system in diseases
Share to Neurological Complications and Syndromes
Share to Renal Transplantation Outcomes and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29758394
DOI: 10.1016/j.bbmt.2018.05.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell TransplantationPMID 29758394Read ↗

Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation–associated thrombotic microangiopathySemantic proximity Read ↗

Hematopoietic stem cell transplant–associated thrombotic microangiopathy: review of pharmacologic treatment optionsSemantic proximity Read ↗

Genetic Factors and the Outcomes of Transplant-Associated Thrombotic MicroangiopathiesSemantic proximity Read ↗

An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed TherapySemantic proximity Read ↗

Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy ( TA ‐ TMA )Semantic proximity Read ↗

Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?Semantic proximity Read ↗

Molecular basis of thrombotic microangiopathy.Semantic proximity Read ↗

Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantationSemantic proximity Read ↗

Transplant-associated thrombotic microangiopathy and acquired nephrotic syndrome: A case report in a 35-month child.Semantic proximity Read ↗

Thrombotic microangiopathy after kidney transplantation.Semantic proximity Read ↗

Risk factors for rejection after deceased donor kidney transplantation: a mono-institutional analysis of paired kidneysSemantic proximity Read ↗

Epidemiology, Outcomes, and Complement Gene Variants in Secondary Thrombotic Microangiopathies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.